Tags
Displaying 31 - 40 of 68
17 Dec 2019
A targeted and personalised method for triggering the body’s immune response could transform how we treat cancer. Thanks to a grant from the European Research Council (ERC), an inspired idea has been developed in the lab and turned into a ground…
A targeted and personalised method for triggering the body’s immune response could transform how we treat cancer. Thanks to a grant from the European Research Council (ERC), an…
A targeted and personalised method for triggering the body’s immune response could transform how we treat cancer. Thanks to a grant from the European…
A targeted and personalised method for triggering the body’s immune response could transform how we treat cancer. Thanks to a grant from the European Research Council (ERC),…
A targeted and personalised method for triggering the body’s immune response could transform how we treat cancer. Thanks to…
03 Dec 2019
The ASTAOMEGA project solves the problems linked to the production of omega-3 and antioxidants at the same time. The team promises higher production rates and improved sustainability at a lower cost.
The ASTAOMEGA project solves the problems linked to the production of omega-3 and antioxidants at the same time. The team promises higher production rates and improved sustainability…
The ASTAOMEGA project solves the problems linked to the production of omega-3 and antioxidants at the same time. The team promises higher production…
The ASTAOMEGA project solves the problems linked to the production of omega-3 and antioxidants at the same time. The team promises higher production rates and improved…
The ASTAOMEGA project solves the problems linked to the production of omega-3 and antioxidants at the same time. The team…
03 Dec 2019
Just days before Sir Peter Radcliffe will receive the Nobel Prize in Stockholm, the European Research Council (ERC) will host him as a speaker in the event “A Sustainable Future for Europe – The Contribution of Frontier Research” in Brussels. This…
Just days before Sir Peter Radcliffe will receive the Nobel Prize in Stockholm, the European Research Council (ERC) will host him as a speaker in the event “A Sustainable Future for…
Just days before Sir Peter Radcliffe will receive the Nobel Prize in Stockholm, the European Research Council (ERC) will host him as a speaker in the…
Just days before Sir Peter Radcliffe will receive the Nobel Prize in Stockholm, the European Research Council (ERC) will host him as a speaker in the event “A Sustainable…
Just days before Sir Peter Radcliffe will receive the Nobel Prize in Stockholm, the European Research Council (ERC) will…
24 Oct 2019
Breast cancer is the most common cancer in women worldwide. Over 2 million new cases were diagnosed in 2018. Although tools of diagnosis and the diversity of treatment have improved assuring now a 90% five-year survival rate, metastatic breast…
Breast cancer is the most common cancer in women worldwide. Over 2 million new cases were diagnosed in 2018. Although tools of diagnosis and the diversity of treatment have improved…
Breast cancer is the most common cancer in women worldwide. Over 2 million new cases were diagnosed in 2018. Although tools of diagnosis and the…
Breast cancer is the most common cancer in women worldwide. Over 2 million new cases were diagnosed in 2018. Although tools of diagnosis and the diversity of treatment have…
Breast cancer is the most common cancer in women worldwide. Over 2 million new cases were diagnosed in 2018. Although tools…
24 May 2019
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel therapies for hundreds of millions of people worldwide suffering from bone cancer, bacterial bone…
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel therapies for hundreds of millions…
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel…
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone diseases, enabling novel therapies for hundreds of…
Multifunctional nanoparticles being developed by EU-funded researchers are set to revolutionise treatments for complex bone…
12 Mar 2019
By the end of 2018, the ERC had funded over 9,000 projects. More than 9,000 incredible stories, all worth telling.Here we showcase some highlights from the last year:
By the end of 2018, the ERC had funded over 9,000 projects. More than 9,000 incredible stories, all worth telling.Here we showcase some highlights from the last year:
By the end of 2018, the ERC had funded over 9,000 projects. More than 9,000 incredible stories, all worth telling.Here we showcase some highlights…
By the end of 2018, the ERC had funded over 9,000 projects. More than 9,000 incredible stories, all worth telling.Here we showcase some highlights from the last year:
By the end of 2018, the ERC had funded over 9,000 projects. More than 9,000 incredible stories, all worth telling.Here we…
11 Feb 2019
A microchip device to detect tumour cells in the blood, at a glanceThere are trillions of cells in the human body of different sizes and shapes. In such a densely populated environment, the chances of detecting a single tumour cell circulating in…
A microchip device to detect tumour cells in the blood, at a glanceThere are trillions of cells in the human body of different sizes and shapes. In such a densely populated environment…
A microchip device to detect tumour cells in the blood, at a glanceThere are trillions of cells in the human body of different sizes and shapes. In…
A microchip device to detect tumour cells in the blood, at a glanceThere are trillions of cells in the human body of different sizes and shapes. In such a densely populated…
A microchip device to detect tumour cells in the blood, at a glanceThere are trillions of cells in the human body of…
24 Jan 2019
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancerPancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very low survival rate with less than 1 per cent of sufferers…
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancerPancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very…
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancerPancreatic cancer is the 4th leading cause of death…
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancerPancreatic cancer is the 4th leading cause of death by cancer in Europe. It…
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancerPancreatic cancer is the…